John Maringwa

1.6k total citations
31 papers, 1.3k citations indexed

About

John Maringwa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Maringwa has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Maringwa's work include Cancer survivorship and care (8 papers), Palliative Care and End-of-Life Issues (6 papers) and Lung Cancer Treatments and Mutations (5 papers). John Maringwa is often cited by papers focused on Cancer survivorship and care (8 papers), Palliative Care and End-of-Life Issues (6 papers) and Lung Cancer Treatments and Mutations (5 papers). John Maringwa collaborates with scholars based in Belgium, United States and Netherlands. John Maringwa's co-authors include Ivo Lambrichts, Emmy Van Kerkhove, Corneel Coens, Andrew Bottomley, Hans‐Henning Flechtner, Madeleine King, Chantal Quinten, Jolie Ringash, Joachim Weis and Francesca Martinelli and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

John Maringwa

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Maringwa Belgium 12 593 358 271 153 151 31 1.3k
Biying Liu China 19 421 0.7× 111 0.3× 125 0.5× 113 0.7× 179 1.2× 72 1.4k
Hooman Khademi Iran 24 450 0.8× 192 0.5× 124 0.5× 86 0.6× 414 2.7× 35 1.9k
Karen Steinberg United States 24 439 0.7× 119 0.3× 249 0.9× 324 2.1× 321 2.1× 65 2.5k
Stephanie A. Navarro Silvera United States 21 414 0.7× 179 0.5× 166 0.6× 215 1.4× 202 1.3× 29 1.3k
Ahmet Özet Türkiye 19 499 0.8× 301 0.8× 40 0.1× 130 0.8× 144 1.0× 153 1.3k
Søren Cold Denmark 26 918 1.5× 292 0.8× 126 0.5× 264 1.7× 241 1.6× 70 2.4k
Chia‐Chu Chang Taiwan 25 133 0.2× 172 0.5× 165 0.6× 82 0.5× 173 1.1× 104 1.5k
Yueping Shen China 24 306 0.5× 161 0.4× 213 0.8× 35 0.2× 146 1.0× 97 1.8k
Joanne Kotsopoulos Canada 32 1.0k 1.7× 159 0.4× 160 0.6× 211 1.4× 140 0.9× 119 2.9k

Countries citing papers authored by John Maringwa

Since Specialization
Citations

This map shows the geographic impact of John Maringwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Maringwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Maringwa more than expected).

Fields of papers citing papers by John Maringwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Maringwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Maringwa. The network helps show where John Maringwa may publish in the future.

Co-authorship network of co-authors of John Maringwa

This figure shows the co-authorship network connecting the top 25 collaborators of John Maringwa. A scholar is included among the top collaborators of John Maringwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Maringwa. John Maringwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serrano, Jean Carlos, John Maringwa, Wouter Willems, et al.. (2025). A Model‐Based Meta‐Analysis Framework Quantifying Drivers of Placebo Response in Atopic Dermatitis Trials. CPT Pharmacometrics & Systems Pharmacology. 15(2). e70150–e70150.
2.
Maringwa, John, Paul M. Diderichsen, & Chandni Valiathan. (2024). Partial Residual Plots as an Integrated Model Diagnostic Tool in Model‐Based Meta‐Analysis. Clinical Pharmacology & Therapeutics. 117(1). 153–161. 1 indexed citations
3.
Singh, Indrajeet, Abhishek G. Sathe, Paul M. Diderichsen, et al.. (2024). Abstract PO1-04-06: Exposure-response analyses of sacituzumab govitecan efficacy and safety in patients with metastatic breast cancer. Cancer Research. 84(9_Supplement). PO1–4. 1 indexed citations
4.
Gupta, Neeraj, Karen L. Reckamp, David Ross Camidge, et al.. (2022). Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC. Clinical and Translational Science. 15(5). 1143–1154. 5 indexed citations
5.
Maringwa, John, et al.. (2020). Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure. Clinical Pharmacology & Therapeutics. 109(6). 1583–1592. 15 indexed citations
6.
7.
Maringwa, John, Matts Kågedal, Ulrika Wählby Hamrén, et al.. (2014). Pharmacokinetic–pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA). The Journal of Clinical Pharmacology. 55(3). 328–335. 11 indexed citations
8.
Quinten, Chantal, Francesca Martinelli, Corneel Coens, et al.. (2013). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer. 120(2). 302–311. 155 indexed citations
9.
Ediebah, Divine, Corneel Coens, John Maringwa, et al.. (2012). Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients. Annals of Oncology. 24(1). 231–237. 12 indexed citations
10.
Maringwa, John, Chantal Quinten, Madeleine King, et al.. (2011). Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Annals of Oncology. 22(9). 2107–2112. 133 indexed citations
11.
Quinten, Chantal, John Maringwa, Carolyn Gotay, et al.. (2011). Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival. JNCI Journal of the National Cancer Institute. 103(24). 1851–1858. 180 indexed citations
12.
Maringwa, John, Chantal Quinten, Madeleine King, et al.. (2010). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer. 19(11). 1753–1760. 131 indexed citations
13.
Maringwa, John, Christel Faes, Helena Geys, et al.. (2009). Application of Penalized Splines in Analyzing Neuronal Data. Biometrical Journal. 51(1). 203–216. 2 indexed citations
14.
Maringwa, John, Corneel Coens, Chantal Quinten, et al.. (2009). 4218 Determining the minimal clinically important difference for health related quality of life scores from the EORTC QLQ-C30 in lung cancer patients: an analysis of pooled data. European Journal of Cancer Supplements. 7(2). 244–244. 2 indexed citations
15.
Maringwa, John, Helena Geys, Ziv Shkedy, et al.. (2008). Analysis of cross‐over designs with serial correlation within periods using semi‐parametric mixed models. Statistics in Medicine. 27(28). 6009–6033. 7 indexed citations
16.
17.
Cuypers, Ann, John Maringwa, Karen Smeets, et al.. (2007). Low cadmium exposure triggers a biphasic oxidative stress response in mice kidneys. Toxicology. 236(1-2). 29–41. 150 indexed citations
18.
Maringwa, John, et al.. (2007). On the Use of Historical Control Data in Pre-Clinical Safety Studies. Journal of Biopharmaceutical Statistics. 17(3). 493–509. 7 indexed citations
19.
Cuypers, Ann, et al.. (2007). Exposing mice to low Cd doses triggers a biphasic oxidative stress response in the kidney: a role for Prdx2 and Nox4?. The FASEB Journal. 21(5). 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Biying Liu Breakdown of academic impact, for papers by Hooman Khademi Breakdown of academic impact, for papers by Karen Steinberg Breakdown of academic impact, for papers by Stephanie A. Navarro Silvera Breakdown of academic impact, for papers by Ahmet Özet Breakdown of academic impact, for papers by Søren Cold Breakdown of academic impact, for papers by Chia‐Chu Chang Breakdown of academic impact, for papers by Yueping Shen Breakdown of academic impact, for papers by Joanne Kotsopoulos
Rankless by CCL
2026